Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia
- PMID: 12140780
- DOI: 10.1038/sj.mp.4001158
Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia
Abstract
Several studies suggest that decreased expression of presynaptic proteins may be characteristic of schizophrenia. We examined one such protein, synapsin, in schizophrenia and bipolar disorder. Samples of hippocampal tissue from controls (n = 13), patients with schizophrenia (n = 16), or bipolar disorder (n = 6), and suicide victims (n = 7) were used. The membrane and cytosolic fractions were analyzed by Western immunoblotting for synapsin using an antibody that detects synapsin Ia, IIa, and IIIa proteins. Synaptophysin was also measured for comparison. Total synapsin was decreased significantly in patients with schizophrenia (P = 0.034) and in bipolar disorder (P = 0.00008) as compared to controls. The synapsin/synaptophysin ratios were decreased in schizophrenia and bipolar disorder, and additionally in suicide victims (P = 0.014). Age, postmortem interval, percentage of protein extracted, and pH of brain were not different between groups. No changes in total synapsin or synaptophysin in the hippocampus were produced by injecting rats with either lithium or haloperidol for 30 days. Reductions in synapsin in both patients with schizophrenia (synapsin IIa and IIIa) and bipolar disorder (synapsin Ia, IIa and IIIa) imply that altered or reduced synaptic function in the hippocampus may be involved in these disorders.
Similar articles
-
VASE-containing N-CAM isoforms are increased in the hippocampus in bipolar disorder but not schizophrenia.Exp Neurol. 1998 Nov;154(1):1-11. doi: 10.1006/exnr.1998.6889. Exp Neurol. 1998. PMID: 9875262
-
Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia.Neurosci Lett. 2007 Jan 10;411(2):123-7. doi: 10.1016/j.neulet.2006.10.031. Epub 2006 Nov 13. Neurosci Lett. 2007. PMID: 17095155
-
Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder.Psychiatry Res. 2010 Jul 30;178(2):374-80. doi: 10.1016/j.psychres.2008.07.012. Epub 2010 May 21. Psychiatry Res. 2010. PMID: 20488553
-
Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia.Hippocampus. 2001;11(5):508-19. doi: 10.1002/hipo.1067. Hippocampus. 2001. PMID: 11732704 Review.
-
Synapsin III: role in neuronal plasticity and disease.Semin Cell Dev Biol. 2011 Jun;22(4):416-24. doi: 10.1016/j.semcdb.2011.07.007. Epub 2011 Jul 30. Semin Cell Dev Biol. 2011. PMID: 21827867 Free PMC article. Review.
Cited by
-
Thiamine deficiency degrades the link between spatial behavior and hippocampal synapsin I and phosphorylated synapsin I protein levels.Behav Brain Res. 2012 Jul 1;232(2):421-5. doi: 10.1016/j.bbr.2012.04.004. Epub 2012 Apr 9. Behav Brain Res. 2012. PMID: 22507301 Free PMC article.
-
Association and expression study of synapsin III and schizophrenia.Neurosci Lett. 2009 Nov 20;465(3):248-51. doi: 10.1016/j.neulet.2009.09.032. Epub 2009 Sep 19. Neurosci Lett. 2009. PMID: 19766700 Free PMC article.
-
Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders.Mol Neurobiol. 2006 Oct;34(2):109-28. doi: 10.1385/MN:34:2:109. Mol Neurobiol. 2006. PMID: 17220533 Review.
-
_target identification for CNS diseases by transcriptional profiling.Neuropsychopharmacology. 2009 Jan;34(1):18-54. doi: 10.1038/npp.2008.172. Epub 2008 Oct 15. Neuropsychopharmacology. 2009. PMID: 18923405 Free PMC article. Review.
-
Differential Expression of Synapsin I and II upon Treatment by Lithium and Valproic Acid in Various Brain Regions.Int J Neuropsychopharmacol. 2018 Jun 1;21(6):616-622. doi: 10.1093/ijnp/pyy023. Int J Neuropsychopharmacol. 2018. PMID: 29618019 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
